These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33951602)

  • 1. Rash during lamotrigine treatment is not always drug hypersensitivity: A retrospective cohort study among children and adults.
    Shirzadi M; Saunes M; Reimers A; Brodtkorb E
    Seizure; 2021 Jul; 89():12-18. PubMed ID: 33951602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Lamotrigine-associated rash.
    Hirsch LJ; Weintraub DB; Buchsbaum R; Spencer HT; Straka T; Hager M; Resor SR
    Epilepsia; 2006 Feb; 47(2):318-22. PubMed ID: 16499755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lamotrigine-induced rash--worth a rechallenge.
    P-Codrea Tigaran S; Sidenius P; Dam M
    Acta Neurol Scand; 2005 Mar; 111(3):191-4. PubMed ID: 15736314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of a lamotrigine-related skin rash: current meta-analysis and postmarketing cohort analysis.
    Wang XQ; Xiong J; Xu WH; Yu SY; Huang XS; Zhang JT; Tian CL; Huang DH; Jia WQ; Lang SY
    Seizure; 2015 Feb; 25():52-61. PubMed ID: 25645637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of long-term lamotrigine in epilepsy.
    Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
    Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-reactivity of skin rashes with current antiepileptic drugs in Chinese population.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Seizure; 2010 Nov; 19(9):562-6. PubMed ID: 20888266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adding lamotrigine to valproate: incidence of rash and other adverse effects. Postmarketing Antiepileptic Drug Survey (PADS) Group.
    Faught E; Morris G; Jacobson M; French J; Harden C; Montouris G; Rosenfeld W
    Epilepsia; 1999 Aug; 40(8):1135-40. PubMed ID: 10448828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Selected Initial Titration Schedules on Safety and Long-Term Effectiveness of Lamotrigine for the Treatment of Mood Disorders.
    Nakamura T; Tomita M; Hirota S; Matsunaga T; Uchimura N
    J Clin Psychopharmacol; 2022 Jul-Aug 01; 42(4):350-356. PubMed ID: 35506599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine hypersensitivity in childhood epilepsy.
    Iannetti P; Raucci U; Zuccaro P; Pacifici R
    Epilepsia; 1998 May; 39(5):502-7. PubMed ID: 9596202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lamotrigine-associated rash: risk/benefit considerations in adults and children.
    Guberman AH; Besag FM; Brodie MJ; Dooley JM; Duchowny MS; Pellock JM; Richens A; Stern RS; Trevathan E
    Epilepsia; 1999 Jul; 40(7):985-91. PubMed ID: 10403224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-A∗24:02 associated with lamotrigine-induced cutaneous adverse drug reactions: A systematic review and meta-analysis.
    Li W; Wang J; Lin H; Shen G
    Medicine (Baltimore); 2020 Dec; 99(52):e23929. PubMed ID: 33350798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
    Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
    J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy.
    Jang HW; Kim SW; Cho YJ; Heo K; Lee BI; Lee SK; Jang IJ; Lee MG; Kim WJ; Lee JH
    Epilepsy Res; 2015 Sep; 115():88-94. PubMed ID: 26220383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lamotrigine-induced severe cutaneous adverse reactions.
    Schlienger RG; Shapiro LE; Shear NH
    Epilepsia; 1998; 39 Suppl 7():S22-6. PubMed ID: 9798758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of lamotrigine.
    Richens A
    Epilepsia; 1994; 35 Suppl 5():S37-40. PubMed ID: 8039469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox Gastaut syndrome).
    Donaldson JA; Glauser TA; Olberding LS
    Epilepsia; 1997 Jan; 38(1):68-73. PubMed ID: 9024186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression in patients with newly diagnosed epilepsy predicts lamotrigine-induced rash: a short-term observational study.
    Park SP
    Epilepsy Behav; 2013 Jul; 28(1):88-90. PubMed ID: 23673289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity reactions to antiepileptic drugs in children.
    Atanasković-Marković M; Janković J; Tmušić V; Gavrović-Jankulović M; Ćirković Veličković T; Nikolić D; Škorić D
    Pediatr Allergy Immunol; 2019 Aug; 30(5):547-552. PubMed ID: 30951222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reintroduction of treatment with lamotrigine in combination with valproate after an initial allergic skin reaction].
    Gélisse P; Crespel A
    Rev Neurol (Paris); 2006 Nov; 162(11):1122-4. PubMed ID: 17086149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamotrigine associated with insomnia.
    Sadler M
    Epilepsia; 1999 Mar; 40(3):322-5. PubMed ID: 10080513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.